GENOCEA BIOSCIENCES INC (GNCA)

US3724274010 - Common Stock

0.051  -0.01 (-15%)

After market: 0.055 +0 (+7.84%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
1.36M1.64M
20.59%		578.003K
EBITDA
YoY % growth
-37.89M
1.41%		-45.85M
-21.01%		-50.53M
-10.21%		-57.936MN/A
EBIT
YoY % growth
-38.99M
1.34%		-46.99M
-20.52%		-52.09M
-10.85%		-42.84M
Operating Margin
N/A-3,455.15%-3,176.22%-7,411.72%
EPS
YoY % growth
-2.24
20.00%		-1.16
48.21%		-0.47
59.48%		-0.74

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 22 Q3 / 22 Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth		-0.18
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-13.974MN/AN/AN/AN/A
EBIT
Q2Q % growth		-8.67M

Recent Earnings VS Estimates Surprises ()
PeriodReportedEstimateDifferenceSurprise
Q1 2022
Q2Q % growth		 -0.22
-29.41%		-0.19-0.03-18.51%
Q4 2021
Q2Q % growth		 -0.19
17.39%		-0.200.016.86%
Q3 2021
Q2Q % growth		 -0.05
37.50%		-0.200.1575.18%
Q2 2021
Q2Q % growth		 -0.06
84.62%		-0.190.1367.68%
Recent Revenue VS Estimates Surprises

Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .

PeriodReportedEstimateDifferenceSurprise
Q1 2022
Q2Q % growth		 270K
∞%		433.5K-163.5K-37.72%
Q4 2021
Q2Q % growth		 %
Q3 2021
Q2Q % growth		 1.64M
264.44%		1.64M∞%
Q2 2021
Q2Q % growth
-100.00%		%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A